Launched by EMIH and prepared by a committee of microbiome experts (members of EMIH), this first-of-its-kind bootcamp is designed as a practical, transdisciplinary and highly participative event. Over two days, industry leaders, product developers, academic...
Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...
The Biocodex Microbiota Institute is pleased to highlight the launch of a new CME-accredited online course, “The Gut Microbiome in Immuno-Oncology”, now available on the Xpeer platform. This course is led by Dr. Arielle Elkrief, medical oncologist and...
• Recognizes the potential of MH002 to address a serious medical condition with high unmet need • Enables accelerated development and increased FDA interactions to streamline review process • MRM Health will be presenting at upcoming Digestive Disease Week (DDW) 2026,...
Read the full article below. MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline 4 September, 2025 – Ghent, Belgium MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based...
The European Microbiome Innovation for Health (EMIH) highly welcomes the initiative of the European Commission to propose a European Biotech Act. This emerging sector needs a proper regulatory framework to ensure patients’ safety and timely access to innovative...
